Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

January 13, 2023

Study Completion Date

November 1, 2027

Conditions

Oligometastatic DiseaseBone MetastasesStereotactic Body Radiotherapy

Interventions

RADIATION

SABR

Two fractionation regimes are available (37.5 Gy in 3 fractions and 30.0 Gy in 3 fractions)

Trial Locations (6)

Rigshospitalet, Copenhagen

Herlev Hospital, Herlev

Odense University Hospital, Odense

Ålesund sjukehus, Ålesund

Aalborg Universitetshospital, Aalborg

St Olavs Universitetssykehus,, Trondheim

All Listed Sponsors

lead

Gitte Fredberg Persson MD PhD

OTHER